F. Morel

757 total citations
30 papers, 222 citations indexed

About

F. Morel is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, F. Morel has authored 30 papers receiving a total of 222 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 10 papers in Epidemiology and 9 papers in Surgery. Recurrent topics in F. Morel's work include Tuberculosis Research and Epidemiology (8 papers), Mycobacterium research and diagnosis (8 papers) and Infectious Diseases and Tuberculosis (5 papers). F. Morel is often cited by papers focused on Tuberculosis Research and Epidemiology (8 papers), Mycobacterium research and diagnosis (8 papers) and Infectious Diseases and Tuberculosis (5 papers). F. Morel collaborates with scholars based in France, Switzerland and Italy. F. Morel's co-authors include Alexandra Aubry, Michèle Fonfrède, Olivier Bourron, Wladimir Sougakoff, Carole E. Aubert, Pablo Michel, Stéphane Jaisson, Georges Baffet, Laurent Corcos and Philippe Gillery and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Journal of Clinical Microbiology and British Journal of Cancer.

In The Last Decade

F. Morel

26 papers receiving 210 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
F. Morel France	9	58	57	54	47	29	30	222
Qinqin Wu China	10	84 1.4×	23 0.4×	70 1.3×	80 1.7×	30 1.0×	37	315
Qingkui Jiang United States	8	58 1.0×	20 0.4×	94 1.7×	101 2.1×	10 0.3×	12	279
V. Spagnolo Italy	8	18 0.3×	22 0.4×	54 1.0×	52 1.1×	36 1.2×	9	247
Naoya Ichimura Japan	8	13 0.2×	40 0.7×	49 0.9×	60 1.3×	29 1.0×	14	168
Arieh Gertler Israel	9	96 1.7×	27 0.5×	46 0.9×	92 2.0×	57 2.0×	19	412
M. J. Ross United States	10	41 0.7×	32 0.6×	14 0.3×	112 2.4×	7 0.2×	20	305
Caterina Cambiaggi Italy	11	34 0.6×	17 0.3×	33 0.6×	111 2.4×	8 0.3×	16	380
Carlos Vázquez Spain	8	170 2.9×	29 0.5×	107 2.0×	44 0.9×	3 0.1×	16	326
Tatsuro Miyamoto Japan	12	25 0.4×	78 1.4×	14 0.3×	125 2.7×	72 2.5×	15	384

Countries citing papers authored by F. Morel

Since Specialization

Citations

This map shows the geographic impact of F. Morel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Morel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Morel more than expected).

Fields of papers citing papers by F. Morel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Morel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Morel. The network helps show where F. Morel may publish in the future.

Co-authorship network of co-authors of F. Morel

This figure shows the co-authorship network connecting the top 25 collaborators of F. Morel. A scholar is included among the top collaborators of F. Morel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Morel. F. Morel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gerussi, Valentina, Thomas Nordahl Petersen, Isabelle Bonnet, et al.. (2025). Evaluation of High-Dose Isoniazid in Multidrug-Resistant Tuberculosis Treatment. Emerging infectious diseases. 31(3). 633–636.

Aubry, Alexandra, Wladimir Sougakoff, Matthieu Revest, et al.. (2022). atpE Mutation in Mycobacterium tuberculosis Not Always Predictive of Bedaquiline Treatment Failure. Emerging infectious diseases. 28(5). 1062–1064. 5 indexed citations

Maitre, Thomas, F. Morel, Florence Brossier, et al.. (2022). How a PCR Sequencing Strategy Can Bring New Data to Improve the Diagnosis of Ethionamide Resistance. Microorganisms. 10(7). 1436–1436. 3 indexed citations

Bonnet, Isabelle, Vincent Enouf, F. Morel, et al.. (2021). A Comprehensive Evaluation of GeneLEAD VIII DNA Platform Combined to Deeplex Myc-TB® Assay to Detect in 8 Days Drug Resistance to 13 Antituberculous Drugs and Transmission of Mycobacterium tuberculosis Complex Directly From Clinical Samples. Frontiers in Cellular and Infection Microbiology. 11. 707244–707244. 20 indexed citations

Chauffour, Aurélie, F. Morel, Florence Reibel, et al.. (2021). A systematic review of Mycobacterium leprae DNA gyrase mutations and their impact on fluoroquinolone resistance. Clinical Microbiology and Infection. 27(11). 1601–1612. 12 indexed citations

Gies, Vincent, Yannick Dieudonné, F. Morel, et al.. (2021). Case Report: Acquired Disseminated BCG in the Context of a Delayed Immune Reconstitution After Hematological Malignancy. Frontiers in Immunology. 12. 696268–696268. 3 indexed citations

Aubry, Alexandra, et al.. (2021). Rapid Molecular Diagnosis of Tuberculosis and Its Resistance to Rifampicin and Isoniazid with Automated MDR/MTB ELITe MGB® Assay. Antibiotics. 10(7). 797–797. 1 indexed citations

Maitre, Thomas, F. Morel, Isabelle Bonnet, et al.. (2021). Sampling strategy for bacteriological diagnosis of intrathoracic tuberculosis. Respiratory Medicine and Research. 79. 100825–100825. 1 indexed citations

Aubry, Alexandra, Thomas Maitre, F. Morel, et al.. (2020). Rational Choice of Antibiotics and Media for Mycobacterium avium Complex Drug Susceptibility Testing. Frontiers in Microbiology. 11. 81–81. 11 indexed citations

10.

Morel, F., et al.. (2020). Place de la biologie moléculaire dans le diagnostic de la tuberculose. Revue des Maladies Respiratoires. 37(5). 412–416. 3 indexed citations

11.

Morel, F., Hervé Jacquier, Marine Desroches, et al.. (2018). Use of Andromas and Bruker MALDI-TOF MS in the identification of Neisseria. European Journal of Clinical Microbiology & Infectious Diseases. 37(12). 2273–2277. 12 indexed citations

12.

Morel, F., Lamine Abdennour, Hayat Belaïd, et al.. (2016). Photo Quiz: A “Non-Gramable” Strain Isolated from a Cerebrospinal Fluid Sample. Journal of Clinical Microbiology. 54(3). 511–511.

13.

Morel, F., et al.. (2015). Helicobacter cinaedi bacteraemia in an HIV-infected patient. Médecine et Maladies Infectieuses. 45(1-2). 41–43. 3 indexed citations

14.

Morel, F., et al.. (2013). Labile or not labile: that is the question…. Annales de biologie clinique. 71(3). 373–376. 3 indexed citations

15.

Corcos, Laurent, Georges Baffet, Frédéric Ezan, et al.. (2012). The association of statins and taxanes: an efficient combination trigger of cancer cell apoptosis. British Journal of Cancer. 106(4). 685–692. 37 indexed citations

16.

Morel, F., et al.. (2001). Improved acid tolerance of a recombinant strain of Escherichia coli expressing genes from the acidophilic bacterium Oenococcus oeni. Letters in Applied Microbiology. 33(2). 126–130. 14 indexed citations

17.

Maetz, J. & F. Morel. (1996). [COMMON ENDOCRINE MECHANISMS OF OSMOREGULATION IN VERTEBRATES].. PubMed. 54. 515–30. 1 indexed citations

18.

Morel, F., et al.. (1965). Description of Argas hoogstraali n. sp. from Madagascar (Acari, Ixodoidea). Acarologia. 7(2). 268–273. 3 indexed citations

19.

Gonick, Harvey C., Milton E. Rubini, L. B. Guze, et al.. (1965). Varia. The Nephron journals/Nephron journals. 2(4). 253–256. 3 indexed citations

20.

Jard, Serge & F. Morel. (1961). [Competitive inhibition of the antidiuretic action of lysine-vasotocin by oxytocin in Rana esculenta].. PubMed. 252. 339–41. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact